IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 8641 - 8650 of 13618 for "Capital markets : Equity" with applied filters

News & Analysis

Helmy, Hamza & Partners, Baker McKenzie Cairo advises National Service Projects Organization on its strategic collaboration with Grifols

02 December 2020 by Helmy Hamza & Partners

Cairo, Egypt, December 2, 2020 - Helmy, Hamza & Partners, Baker McKenzie Cairo office, has represented the National Service Projects Organization (NSPO), on a strategic joint venture with Grifols, one of the world's leading producers of plasma-derived medicines. The collaboration is a significant opportunity to develop the Egyptian plasma-derivatives market and promote its self-sufficiency.
News & Analysis

GSK Stockmann promotes fourteen lawyers from their own ranks

16 November 2020 by GSK

On the occasion of their partner meeting on 13th/14th November, GSK Stockmann appointed three new Equity Partners, nine Local Partners and two Counsel from their own ranks. In doing so, the law firm continues to pursue its (inter)national growth targets even during Corona’s challenging times, focussing above all on the development and encouragement of its own up-and-coming legal talents.
News & Analysis

Homburger advised UBS Group AG on its issuance of EUR 1.5 bn Fixed Rate | Fixed Rate Callable Senior Notes under its Senior Debt Programme

10 November 2020 by Homburger

On November 5, 2020, UBS Group AG (UBS) successfully completed its issuance of EUR 1.5 bn in aggregate principal amount of Fixed Rate|Fixed Rate Callable Senior Notes due November 2028 (the Notes) under its Senior Debt Programme.
News & Analysis

Luxembourg: A growth outlook in a new reality

04 November 2020 by GSK

Q&A with Marcus Peter and Irina Stoliarova discussing the key trends currently driving growth and development within Luxembourg’s funds industry.
News & Analysis

Homburger advised Molecular Partners in connection with a collaboration with Novartis to develop DARPin® therapies designed for potential use against COVID-19

29 October 2020 by Homburger

On October 28, 2020, Molecular Partners AG (SIX: MOLN) (Molecular Partners), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin
News & Analysis

Homburger advised Credit Suisse AG in connection with the issuance of CHF 265 m Bonds by Athene

26 October 2020 by Homburger

Athene Global Funding issued CHF 265 m Bonds in the form of a GIC bond
News & Analysis

RTPR advises Innova on PayPoint and Payzone acquisition

22 October 2020 by Radu Tărăcilă Pădurari Retevoescu

RTPR has advised private equity fund Innova Capital in relation to the acquisition of PayPoint Services SRL and Payzone SA from PayPoint group which is listed on the London Stock Exchange
News & Analysis

Turkey: Anadolu Cam, Denizli Cam, Paşabahçe, Soda Sanayii and Trakya Cam were Merged Under Şişecam

21 October 2020 by Erdem & Erdem

Five companies of the Şişecam Group, four of which are publicly held, namely
News & Analysis

Strategic partnership between ODDO BHF and Landolt & Cie

21 October 2020 by Lenz & Staehelin

On 15 October 2020, ODDO BHF, the leading Franco-German financial institution, and Landolt & Cie, the oldest private bank in French speaking part of Switzerland, announced the entry
News & Analysis

Homburger advises VectivBio on USD 110 m Crossover Financing

19 October 2020 by Homburger

On October 15, 2020, VectivBio AG, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, announced that...
Load more